Shire plc (ADR) (NASDAQ:SHPGY)

CAPS Rating: 4 out of 5

A pharmaceutical company that focuses on meeting the needs of the specialist physician.

Recs

1
Player Avatar Iznogoud888 (68.76) Submitted: 3/25/2008 2:48:42 PM : Outperform Start Price: $60.40 SHPGY Score: +45.32

A rise in Vyvanse market share will drive the value up. Potential takeover.

Featured Broker Partners


Advertisement